Genome Editing/Genome Engineering Market

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025

Report Code: BT 3380 Jun, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Genome Editing/Genome Engineering Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Genome Editing/Genome Engineering Market

Request For Special Pricing

[147 Pages Report] The global genome editing/genome engineering market size is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Market growth is largely driven by factors such as the availability of government funding and growth in the number of genomics projects. However, the high cost of genomic equipment will restrain the growth of this market.

Genome Editing/Genome Engineering Market

By technology, CRISPR accounted for the largest share of the genome editing/genome engineering market.

CRISPR accounted for the largest share of the genome editing/genome engineering market, by technology, in 2019. The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN.

Pharmaceutical companies accounted for the largest share of the market, by end user.

The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. The increasing prevalence of infectious diseases and cancer is driving research activities worldwide. This is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

Genome Editing/Genome Engineering Market by Region

North America accounted for the largest share of the genome editing/genome engineering market.

The market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global genome editing/genome engineering market, closely followed by Europe. The large share of North America can be attributed to factors such as the development of gene therapy in the US, the increasing use of genetically modified crops, the rising prevalence of infectious diseases and cancer, and the availability of research grants and funding are propelling market growth in North America.

Key Market Players

The major companies in the genome editing/genome engineering market include Thermo Fisher Scientific (US), Merck & Co (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg) and Sangamo Therapeutics (US).

Thermo Fisher Scientific (US) is the leading player in the global genome editing market. Under its life sciences segment, the company offers a variety of instruments and reagents for the analysis of DNA. Moreover, the company invests in R&D activities to increase its offerings. The company primarily focuses on inorganic growth strategies such as agreements, collaborations, and partnerships for increasing its share in the market. The company has succeeded in creating a strong foothold in the genome editing market owing to its diversified product portfolio, wide geographic reach, and focus on inorganic growth.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Values (USD)

Segments Covered

Technology, Application, Product & Service, End User, and Region

Geographies Covered

North America (US, Canada), Europe (Germany, UK, France, and RoE), APAC (China, Japan, India, RoAPAC) and RoW (LATAM, MEA)

Top Companies Covered

Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), Sangamo Therapeutics (US), Editas Medicine (US), CRISPR Therapeutics (Switzerland), Precision Biosciences (US), Oxford Genetics (UK), Intellia Therapeutics (US), Synthego (US), Vigene Biosciences (US), EpiGenie (US), Integrated DNA Technologies (US), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Creative Biogene (US), Agilent Technologies (US), Danaher (US), ToolGen (South Korea), Cellecta (US), Genecopoeia (US), and Calyxt (US)

Based on technology:

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies

Based on application:

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery & Development
  • Other Applications

Based on product & service:

  • Reagents & Consumables
  • Software & Systems
  • Services

Based on end user:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Government Research Institutes

Based on region:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • RoAPAC
  • RoW
    • LATAM
    • MEA

Recent Developments:

  • In 2020, New England Biolabs collaborated with ERS Genomics to develop and commercialize CRISPR gene editing tools and reagents
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio to access Brammer Bio’s expertise in manufacturing vectors for genes and cell therapies
  • In 2019, Horizon Discovery launched predesigned synthetic single-guide RNA (sgRNA) to aid researchers in achieving targeted gene knockouts and conducting DNA-gene free editing

Key questions addressed by the report:

  • Who are the major players in the genome editing/genome engineering market?
  • What are the regional growth trends and the largest revenue-generating regions in the genome editing/genome engineering market?
  • What are the major drivers and challenges in the genome editing/genome engineering market?
  • What are the major application segments in the genome editing/genome engineering market?
  • What are the major end users in the genome editing/genome engineering market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 19)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 23)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
    2.2 MARKET DATA ESTIMATION & TRIANGULATION
           2.2.1 DATA TRIANGULATION
    2.3 MARKET ESTIMATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 28)

4 PREMIUM INSIGHTS (Page No. - 31)
    4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW
    4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY SOLUTION AND COUNTRY (2019)
    4.3 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION (USD MILLION)
    4.4 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2019

5 MARKET OVERVIEW (Page No. - 34)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS: DRIVERS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising government funding and growth in the number of genomics projects
                    5.2.1.2 Expanding application areas of genomics
                    5.2.1.3 Introduction of CRISPR-Cas9
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Extensive use of genome editing in personalized medicine
                    5.2.2.2 Emerging markets
           5.2.3 CHALLENGES
                    5.2.3.1 High equipment costs
    5.3 VALUE CHAIN ANALYSIS
    5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET

6 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY (Page No. - 39)
    6.1 INTRODUCTION
    6.2 CRISPR
           6.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES
    6.3 TALEN
           6.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN
    6.4 ZFN
           6.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH
    6.5 ANTISENSE
           6.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
    6.6 OTHER TECHNOLOGIES

7 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION (Page No. - 51)
    7.1 INTRODUCTION
    7.2 CELL LINE ENGINEERING
           7.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH
    7.3 GENETIC ENGINEERING
           7.3.1 ANIMAL GENETIC ENGINEERING
                    7.3.1.1 Use of animal simulation models in research to increase the demand for genome editing
           7.3.2 PLANT GENETIC ENGINEERING
                    7.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops
    7.4 DIAGNOSTIC APPLICATIONS
           7.4.1 GROWING APPLICATION HORIZON IN DIAGNOSTICS WILL FAVOR MARKET GROWTH
    7.5 DRUG DISCOVERY & DEVELOPMENT
           7.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH
    7.6 OTHER APPLICATIONS

8 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE (Page No. - 64)
    8.1 INTRODUCTION
    8.2 REAGENTS & CONSUMABLES
           8.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE
    8.3 SOFTWARE & SYSTEMS
           8.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE
    8.4 SERVICES
           8.4.1 WIDE APPLICATION OF SERVICES TO INCREASE MARKET GROWTH

9 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER (Page No. - 72)
    9.1 INTRODUCTION
    9.2 PHARMACEUTICAL COMPANIES
           9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES
    9.3 BIOTECHNOLOGY COMPANIES
           9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES
    9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
           9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH

10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION (Page No. - 80)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                       10.2.1.1 US dominates the North American market
             10.2.2 CANADA
                       10.2.2.1 Availability of research funding in Canada drives the market growth
     10.3 EUROPE
             10.3.1 UK
                       10.3.1.1 UK is the largest market for genome engineering in Europe
             10.3.2 FRANCE
                       10.3.2.1 Government funding for genomics and rising investments into research show potential for market growth
             10.3.3 GERMANY
                       10.3.3.1 Strong academic base and rising awareness are key growth drivers in Germany
             10.3.4 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 CHINA
                       10.4.1.1 China to hold the largest share of the market in the Asia Pacific
             10.4.2 JAPAN
                       10.4.2.1 Focus on cancer research showcases favorable scenario for the market in Japan
             10.4.3 INDIA
                       10.4.3.1 Growing number of startups and government support indicates growth potential
             10.4.4 REST OF ASIA PACIFIC
     10.5 ROW
             10.5.1 LATAM
                       10.5.1.1 Latin America is an attractive market for genomics in the RoW
             10.5.2 MIDDLE EAST & AFRICA
                       10.5.2.1 Rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth

11 COMPETITIVE LANDSCAPE (Page No. - 112)
     11.1 INTRODUCTION
     11.2 MARKET RANKING ANALYSIS
     11.3 MARKET EVALUATION FRAMEWORK
     11.4 COMPETITIVE LEADERSHIP MAPPING
             11.4.1 VISIONARY LEADERS
             11.4.2 DYNAMIC DIFFERENTIATORS
             11.4.3 INNOVATORS
             11.4.4 EMERGING COMPANIES
     11.5 COMPETITIVE SCENARIO
             11.5.1 KEY PRODUCT LAUNCHES
             11.5.2 KEY PARTNERSHIPS & COLLABORATIONS
             11.5.3 KEY ACQUISITIONS

12 COMPANY PROFILES (Page No. - 117)
(Business overview, Products and Services offered, Recent developments, MNM view)*
     12.1 THERMO FISHER SCIENTIFIC
     12.2 MERCK
     12.3 HORIZON DISCOVERY
     12.4 GENSCRIPT
     12.5 SANGAMO THERAPEUTICS
     12.6 LONZA
     12.7 EDITAS MEDICINE
     12.8 CRISPR THERAPEUTICS
     12.9 EUROFINS SCIENTIFIC
     12.10 PRECISION BIOSCIENCES
     12.11 OXFORD GENETICS
     12.12 INTELLIA THERAPEUTICS
     12.13 SYNTHEGO
     12.14 VIGENE BIOSCIENCES
     12.15 EPIGENIE
     12.16 INTEGRATED DNA TECHNOLOGIES
     12.17 NEW ENGLAND BIOLABS
     12.18 ORIGENE TECHNOLOGIES
     12.19 TRANSPOSAGEN BIOPHARMACEUTICALS
     12.20 CREATIVE BIOGENE

*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 141)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS


LIST OF TABLES (154 Tables) 

TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 2 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018–2025 (USD MILLION)
TABLE 3 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 4 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION)
TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 49 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 53 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 54 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 ROW: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 59 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 ROW: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 64 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 ROW: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 70 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 71 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ROW: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 91 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 93 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 94 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 95 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 96 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 97 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 98 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 104 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 105 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 106 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 107 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 108 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 109 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 110 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 111 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 113 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 114 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2017–2025 (USD MILLION)
TABLE 115 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 116 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 117 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 118 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 119 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 120 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 122 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 123 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 124 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 125 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 126 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 127 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 128 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 129 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 130 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 131 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 132 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 133 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 134 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 135 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 136 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 137 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 138 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 139 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 140 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 141 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 142 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 143 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 144 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 145 ROW: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 146 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 147 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 148 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 149 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 150 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 151 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 152 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 153 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 154 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH WAS THE MAJOR STRATEGY ADOPTED BY MAJOR PLAYERS IN 2017
 

LIST OF FIGURES (25 Figures)
 
FIGURE 1 BREAKDOWN OF PRIMARIES
FIGURE 2 DATA TRIANGULATION METHODOLOGY
FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE (USD BILLION)
FIGURE 4 GENOME EDITING/GENOME ENGINEERING MARKET CAGR PROJECTIONS FROM AN ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
FIGURE 5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY APPLICATION, 2019
FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2020−2025
FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING/GENOME ENGINEERING MARKET
FIGURE 9 RISING R&D FUNDING AND HIGH PREVALENCE OF INFECTIOUS DISEASES ARE THE PRIMARY GROWTH DRIVERS FOR THE MARKET
FIGURE 10 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET
FIGURE 11 CELL LINE ENGINEERING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 12 PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
FIGURE 13 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
FIGURE 14 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2020 VS. 2025
FIGURE 15 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
FIGURE 16 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
FIGURE 17 COMPANY RANKING IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019
FIGURE 18 GENOME EDITING/GENOME ENGINEERING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 20 MERCK: COMPANY SNAPSHOT (2019)
FIGURE 21 HORIZON DISCOVERY: COMPANY SNAPSHOT (2018)
FIGURE 22 GENSCRIPT: COMPANY SNAPSHOT (2019)
FIGURE 23 SANGAMO THERAPEUTICS: COMPANY OVERVIEW (2019)
FIGURE 24 LONZA: COMPANY SNAPSHOT (2019)
FIGURE 25 EDITAS MEDICINE: COMPANY SNAPSHOT (2018)
FIGURE 26 CRISPR THERAPEUTICS: COMPANY SNAPSHOT (2019)
FIGURE 27 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 28 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2019)

The study involved two major activities in estimating the current size of the genome editing/genome engineering market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Revenue-based estimation approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources such as Hoovers, Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to identify and collect information useful for this technical, market-oriented, and commercial study of the genome editing/genome engineering market. These secondary sources include government sources, annual reports, SEC filings, investor presentations, business magazines & research journals, press releases, and trade, business, and professional associations.

Primary Research

The genome editing/genome engineering market comprises several stakeholders such as research institutes, solution providers, pharmaceutical & biotechnology companies, CROs, government associations, healthcare associations/institutes, genome editing/genome engineering service and software providing companies, and market research & consulting firms. Several primary interviews were conducted with market experts from both the demand side (such as personnel from managers in healthcare provider organizations) and the supply side (such as C-level and D-level executives and product managers) across four major regions—North America, Europe, Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Genome Editing/Genome Engineering Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For calculating the global market value, segmental revenues were arrived at based on the revenue mapping of major players active in the genome editing/genome engineering market. This process involved the following steps:

  • Generating a list of the major global players operating in the genome editing/genome engineering market
  • Mapping the annual revenues generated by major global players from the genome editing/genome engineering market (or the nearest reported business unit/product, service category)
  • Estimating the revenue from the related market and extrapolating to the global number as of 2019
  • Calculating 100% of the global value of the genome editing/genome engineering market based on the bottom-up approach and CAGR projections

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the genome editing/genome engineering market.

Report Objectives

  • To define, describe, and forecast the genome editing/genome engineering market, by technology, application, product & service, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the global genome editing/genome engineering market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall global genome editing/genome engineering market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size (by value) of market segments with respect to four main regions (along with countries)—North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players and comprehensively analyze their core competencies in terms of key market developments and growth strategies
  • To track and analyze competitive developments such as product & service launches, acquisitions, agreements, partnerships, collaborations, and expansions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographic Analysis

  • Further breakdown of the European genome editing/genome engineering market into Spain and Italy

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
BT 3380
Published ON
Jun, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Genome Editing/Genome Engineering Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home